News and Events

PathoQuest Appoints Colette Côté as Chief Portfolio Officer and General Manager of the Company’s U.S. Subsidiary WAYNE, PA, and PARIS, FRANCE – March 18, 2021 – PathoQuest, a pioneer in the development and application of novel Next Generation Sequencing (NGS)-based...

PathoQuest Appoints Guillaume Deplaine, Ph.D., as Head of Operations Dr. Guillaume Deplaine has 10 years of experience in the Biotechnology industry. Prior to joining PathoQuest, Dr. Deplaine was the Quality Control and Analytical Development Head at CELLforCURE a...